Medtronic and Bayer expand partnership to treat American diabetes patients

11:55 am by | 0 Comments

Medtronic Inc. and Bayer HealthCare, part of Bayer AG, announced Monday that they have expanded an international alliance to now include the U.S. market in a bid to tackle diabetes.

Since 2007, the Fridley, Minnesota company, which makes new innovative medical devices, and the Tarrytown, New York company have partnered overseas in more than 20 countries. Through this partnership, patients who use Medtronic’s MiniMed Paradigm insulin pumps and its Guardian REAL-Time continuous glucose monitoring (CGM) system can also avail of Bayer’s CONTOUR Link meter.

Medtronic and Bayer’s partnership also seeks to develop next-generation diabetes management solutions and  state-of-the art wireless glucose meters globally.

“We are excited to work with Bayer to develop and deliver future integrated solutions that are even smaller and easier to use, with accuracy that surpasses today’s standards in diabetes management,” said Katie Szyman, president of the diabetes business and senior vice president at Medtronic, in a statement.


Copyright 2015 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author